Literature DB >> 22796000

Two novel deletions in hypotonia-cystinuria syndrome.

Luc Régal1, Halil Ibrahim Aydin, Anne-Marie Dieltjens, Hilde Van Esch, Inge Francois, Ilyas Okur, Cengiz Zeybek, Sandra Meulemans, Christine Van Mol, Lore Van Bruwaene, Siao-Hann Then, Jaak Jaeken, John Creemers.   

Abstract

Hypotonia-cystinuria syndrome (HCS) is an autosomal recessive disorder caused by combined deletions of SLC3A1 and PREPL. Clinical features include cystinuria, neonatal hypotonia with spontaneous improvement, poor feeding in neonates, hyperphagia in childhood, growth hormone deficiency, and variable cognitive problems. Only 14 families with 6 different deletions have been reported. Patients are often initially misdiagnosed, while correct diagnosis enables therapeutic interventions. We report two novel deletions, further characterizing the clinical and molecular genetics spectrum of HCS.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796000     DOI: 10.1016/j.ymgme.2012.06.011

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  6 in total

1.  First cardiac manifestation of hypotonia-cystinuria syndrome.

Authors:  Mustafa Kılıç; Ahmet Cevdet Ceylan; Utku Arman Örün; Esra Kılıç
Journal:  Metab Brain Dis       Date:  2018-04-07       Impact factor: 3.584

2.  PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.

Authors:  Luc Régal; Xin-Ming Shen; Duygu Selcen; Chantal Verhille; Sandra Meulemans; John W M Creemers; Andrew G Engel
Journal:  Neurology       Date:  2014-03-07       Impact factor: 9.910

Review 3.  The second point mutation in PREPL: a case report and literature review.

Authors:  Sebastian Silva; Noriko Miyake; Carolina Tapia; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2018-02-26       Impact factor: 3.172

4.  PREPL deficiency: delineation of the phenotype and development of a functional blood assay.

Authors:  Luc Régal; Emma Mårtensson; Isabelle Maystadt; Nicol Voermans; Damien Lederer; Alberto Burlina; María Jesús Juan Fita; A Jeannette M Hoogeboom; Mia Olsson Engman; Tess Hollemans; Meyke Schouten; Sandra Meulemans; Tord Jonson; Inge François; David Gil Ortega; Erik-Jan Kamsteeg; John W M Creemers
Journal:  Genet Med       Date:  2017-07-20       Impact factor: 8.822

5.  Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function.

Authors:  Sitvanit Haziza; Roberta Magnani; Dima Lan; Omer Keinan; Ann Saada; Eli Hershkovitz; Nurit Yanay; Yoram Cohen; Yoram Nevo; Robert L Houtz; Val C Sheffield; Hava Golan; Ruti Parvari
Journal:  PLoS Genet       Date:  2015-08-06       Impact factor: 5.917

6.  Deletion of PREPl causes growth impairment and hypotonia in mice.

Authors:  Anna Mari Lone; Mathias Leidl; Amanda K McFedries; James W Horner; John Creemers; Alan Saghatelian
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.